The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC).
 
John Yi
No Relationships to Disclose
 
Jeffrey Melson Clarke
No Relationships to Disclose
 
Patrick Healy
No Relationships to Disclose
 
Xiaofei F. Wang
No Relationships to Disclose
 
Debra Shoemaker
No Relationships to Disclose
 
Mark W. Onaitis
No Relationships to Disclose
 
Chelsae Dumbauld
No Relationships to Disclose
 
Robyn Osborne
No Relationships to Disclose
 
Jeffrey Crawford
Consulting or Advisory Role - AVEO; Bayer; Boehringer Ingelheim; Merck; Novartis; Pfizer
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer; Clovis Oncology; Gilead Sciences (Inst); GTx (Inst); MedImmune (Inst); Morphotek (Inst)
Travel, Accommodations, Expenses - Kirin Pharmaceuticals; Roche
Other Relationship - Celgene; G1 Therapeutics; Janssen; Merrimack; Roche
 
David Harpole
No Relationships to Disclose
 
Thomas A. D'Amico
No Relationships to Disclose
 
Frank Dunphy
No Relationships to Disclose
 
Jared Christensen
No Relationships to Disclose
 
Neal Ready
No Relationships to Disclose
 
Kent Weinhold
No Relationships to Disclose